Immune Signatures May Predict Adverse Events in Patients Taking Immunotherapy
A study by researchers from the Johns Hopkins Kimmel Cancer Center and its Bloomberg~Kimmel Institute for Cancer Immunotherapy have identified […]
A study by researchers from the Johns Hopkins Kimmel Cancer Center and its Bloomberg~Kimmel Institute for Cancer Immunotherapy have identified […]
A novel test developed by Johns Hopkins Kimmel Cancer Center investigators could give gastroenterologists insight…
Using genetic engineering techniques, investigators at the Johns Hopkins Kimmel Cancer Center…
A new drug for treatment of a type of brain cancer, called IDH-mutant low-grade glioma, was approved…
In a recent study, researchers at Johns Hopkins Medicine suggest the cell’s messenger RNA…
Researchers at the Johns Hopkins Kimmel Cancer Center’s Sol Goldman Pancreatic Cancer Research Center have developed a 3D genomic profiling technique…
Using artificial intelligence technology to identify patterns of DNA fragments associated with lung cancer…
According to the Skin Cancer Foundation, more than 9,500 people are diagnosed with skin cancer every day in the U.S. More than two people die of the disease every hour.
Variations in three genes related to maintaining the length of telomeres — protective DNA caps on chromosomes — […]
Location, race and insurance status play a significant part in the odds of a patient being diagnosed with […]
Researchers have found a novel therapy that reprograms immune cells to promote antitumor activity. This therapy helped shrink […]
Learn how a multidisciplinary team devised an innovative three-part surgery to use Vincent’s fibula to construct a new […]
A new combination treatment for urothelial cancer nearly doubled patient survival rates in a new international trial. Combining […]
Age-related changes that cause the skin to stiffen and become less elastic may also contribute to higher rates […]
Targeting a non-encoding stretch of RNA may help shrink tumors caused by an aggressive type of brain cancer […]